• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Device Problem Microbial Contamination of Device (2303)
Patient Problem Unspecified Infection (1930)
Event Date 09/04/2020
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.Additional devices gore® excluder® aaa endoprosthesis (b)(4) and (b)(4) being reported separately under case # (b)(4).A review of the manufacturing and sterilization records for the devices is currently in progress.
 
Event Description
The following was reported to gore: on (b)(6) 2020, the patient underwent an endovascular procedure to treat an abdominal aortic aneurysm and a left common iliac artery aneurysm using a gore® excluder® aaa endoprosthesis.The left common iliac artery also had stenosis, so a gore® viabahn® vbx balloon expandable endoprosthesis (item/serial # unk) was implanted distal to the left leg of the gore® excluder® aaa endoprosthesis.It was also reported that non-gore bare metal stents were implanted bilaterally because the terminal aorta was narrow.On an unknown date in 2020 (around 3 weeks after the initial procedure), the patient had a fever, and infection of the endoprostheses was suspected.Reportedly, inflammatory response was especially strong around the proximal and distal aspects.No treatment details were reported.The patient is being monitored.The physician reported that the cause of the infection was unknown.Also, the physician reportedly considered that it was possible that there was a pre-existing infectious area in the aneurysm and intraprocedural manipulation caused development of the infection.However, it was also reported no infection was observed at the pre-procedural blood test.
 
Manufacturer Narrative
H.6.Method code 1: 4119 the requested lot number remains unknown, therefore a review of the manufacturing and sterilization records could not be conducted.
 
Manufacturer Narrative
H.1.Upon further investigation, it was noted that the possible infection was being monitored and did not require any known treatment and therefore the report is being retracted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10673471
MDR Text Key211300559
Report Number2017233-2020-01347
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 07/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received06/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SEE H.10./11.
Patient Outcome(s) Hospitalization; Other;
-
-